Novelty of Active Ingredients in High-Cost Brand-Name Drugs

Por Jung, Emily H., Sarpatwari, Ameet, Kesselheim, Aaron S.
Publicado no J Gen Intern Med (2020)

FDA and EMA Biosimilar Approvals

Por Jung, Emily H., Sarpatwari, Ameet, Kesselheim, Aaron S., Sinha, Michael S.
Publicado no J Gen Intern Med (2019)

Assessing the Justification, Funding, Success, and Survival Outcomes of Randomized Noninferiority Trials of Cancer Drugs: A Systematic Review and Pooled Analysis

Por Gyawali, Bishal, Tessema, Frazer A., Jung, Emily H., Kesselheim, Aaron S.
Publicado no JAMA Netw Open (2019)

Desmopressin and the risk of hyponatremia: A population-based cohort study

Por Fralick, Michael, Schneeweiss, Sebastian, Wallis, Christopher J. D., Jung, Emily H., Kesselheim, Aaron S.
Publicado no PLoS Med (2019)

Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis

Por D’Andrea, Elvira, Kesselheim, Aaron S., Franklin, Jessica M., Jung, Emily H., Hey, Spencer Phillips, Patorno, Elisabetta
Publicado no Cardiovasc Diabetol (2020)